The record
In a March 1975 rulemaking that finalized provisions for parenteral-drug filters, FDA stated that it would delay final regulation of talc until an acceptable method to determine asbestos-form particles in talc could be developed.
Claim scope
FDA’s stated 1975 action and methodological rationale in the cited food-and-drug rulemaking.
What this source does not establish
A formal withdrawal of the talc provisions, a cosmetic-talc rule, the composition of a particular product, scientific causation, or individual health effects.
Limitations
The primary document says “delay.” Any stronger characterization, including “withdrawal,” requires a separately cited source and must remain distinguished from this record’s 1975 regulatory action.
Source
Federal Register Notice — 40 FR 11865–66 (Mar. 14, 1975), “Asbestos-Form Particles in Drugs for Parenteral Injection,” section explaining the delayed talc provisions